First Solar stock price target raised to $123 from $104 at Argus Research
(END) Dow Jones Newswires
August 05, 2022 09:01 ET (13:01 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Rafael Holdings, Inc. is a holding company. The Company owns interests in clinical and early-stage pharmaceutical companies and commercial real estate assets. The Company is focused on the discovery of cancer and immune metabolism therapeutics. The Company operates through two segments: Pharmaceuticals and Real Estate. The Pharmaceuticals segment is comprised of preferred and common equity interests and the Warrant to purchase equity interests in Rafael Pharmaceuticals, a majority equity interest in LipoMedix, Barer, Levco, Farber and Rafael Medical Devices. The Real Estate segment consists of the Company's real estate holdings associated with a portion of an office building in Israel.
|
|
|
|
|
(END) Dow Jones Newswires
August 05, 2022 09:01 ET (13:01 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
Copyright © 2023. All rights reserved.